pSR348
(Plasmid
#124713)
-
PurposeExpression of narX under Ptac
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 124713 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepACYCDuet-1
- Total vector size (bp) 5088
-
Vector typeBacterial Expression, Synthetic Biology
Growth in Bacteria
-
Bacterial Resistance(s)Spectinomycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert 1
-
Gene/Insert namenarX
-
Insert Size (bp)1794
-
Entrez GenenarX (a.k.a. b1222, ECK1216, frd1, frdR, narR)
Gene/Insert 2
-
Gene/Insert namelacI
-
Insert Size (bp)1080
-
MutationS193* - LacI is truncated and likely deactivated. Please see depositor comments below.
-
Entrez GenelacI (a.k.a. b0345, ECK0342)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
LacI is truncated and likely deactivated in this plasmid. This causes NarX, which is transcribed via the LacI repressible promoter Ptac, to be constitutively expressed.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSR348 was a gift from Jeffrey Tabor (Addgene plasmid # 124713 ; http://n2t.net/addgene:124713 ; RRID:Addgene_124713) -
For your References section:
Rewiring bacterial two-component systems by modular DNA-binding domain swapping. Schmidl SR, Ekness F, Sofjan K, Daeffler KN, Brink KR, Landry BP, Gerhardt KP, Dyulgyarov N, Sheth RU, Tabor JJ. Nat Chem Biol. 2019 Jul;15(7):690-698. doi: 10.1038/s41589-019-0286-6. Epub 2019 May 20. 10.1038/s41589-019-0286-6 PubMed 31110305